{"id":898762,"date":"2025-10-22T08:37:03","date_gmt":"2025-10-22T12:37:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/new-heartflow-pci-navigator-to-equip-interventional-cardiologists-with-pre-procedural-insights-to-enable-pci-planning\/"},"modified":"2025-10-22T08:37:03","modified_gmt":"2025-10-22T12:37:03","slug":"new-heartflow-pci-navigator-to-equip-interventional-cardiologists-with-pre-procedural-insights-to-enable-pci-planning","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/new-heartflow-pci-navigator-to-equip-interventional-cardiologists-with-pre-procedural-insights-to-enable-pci-planning\/","title":{"rendered":"New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning"},"content":{"rendered":"
\n

\n PLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning<\/em>\n <\/p>\n

\n NAVIGATE-PCI registry to enroll approximately 2,500 patients across approximately 30 sites to evaluate the impact of CT-guided PCI planning in real-world practice<\/em>\n <\/p>\n

MOUNTAIN VIEW, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today introduced Heartflow PCI Navigator, the newest addition to the Heartflow One platform. PCI Navigator is the only integrated, AI-driven percutaneous coronary interventions (PCI) planning tool that gives interventional cardiologists a patient-specific 3D model \u2014 detailing anatomy, plaque composition, and lesion-specific physiology \u2014 all aligned to optimize potential stent placement. For the first time, interventional cardiologists can plan PCIs with relevant information brought together in one intuitive view before their patients are in the cath lab.<\/p>\n

Heartflow will showcase PCI Navigator with live demonstrations at Heartflow\u2019s exhibit booth (#2155) at the upcoming Transcatheter Cardiovascular Therapeutics (TCT\u00ae<\/sup>) conference, taking place from October 25-28, 2025, in San Francisco. The company will also present the PLAN CALCIUM study (abstract TCT 417) at the conference on October 26 at 8:30 a.m. PDT.<\/p>\n

PCI Navigator delivers a streamlined view of essential information for cath lab decision-making by integrating all relevant measurements \u2014 including IVUS-like and FFR-like pullback visualizations \u2014 into one seamless experience, which typically requires significant time and effort to obtain in the cath lab.<\/p>\n

\u201cInterventional cardiologists make some of the most critical decisions in coronary care, often with limited information before a case begins. CT-guided PCI addresses that information gap, harnessing insights from the CCTA pathway into a pre-procedural plan to provide physicians the clarity they need for each case. PCI Navigator puts Heartflow at the forefront of that shift,\u201d said Campbell Rogers, M.D., F.A.C.C., Chief Medical Officer of Heartflow. \u201cCCTA with Heartflow analysis helps ensure that all patients warranting invasive management are directed to the cath lab, while also reducing invasive angiograms and improving efficiency. PCI Navigator enhances planning for these patients by integrating anatomy, plaque, and lesion-specific physiology for the interventionalist\u2019s review and input before the procedure.\u201d<\/p>\n

\n PCI Navigator Will Deliver a Streamlined View of Essential Information for Cath Lab Decision-making<\/strong>\n <\/p>\n

This includes:<\/p>\n